| Primary |
| Drug Use For Unknown Indication |
22.1% |
| Colon Cancer |
19.5% |
| Colorectal Cancer |
12.3% |
| Rectal Cancer |
8.8% |
| Colorectal Cancer Metastatic |
5.7% |
| Colon Cancer Metastatic |
5.0% |
| Premedication |
4.9% |
| Gastric Cancer |
4.6% |
| Prophylaxis |
2.5% |
| Colon Cancer Stage Iii |
2.0% |
| Hypertension |
2.0% |
| Nausea |
1.6% |
| Pancreatic Carcinoma |
1.4% |
| Metastatic Gastric Cancer |
1.3% |
| Pain |
1.3% |
| Bile Duct Cancer |
1.1% |
| Metastases To Liver |
1.1% |
| Product Used For Unknown Indication |
1.0% |
| Neoplasm Malignant |
0.9% |
| Chemotherapy |
0.9% |
|
| Vomiting |
17.1% |
| Laryngospasm |
12.4% |
| Death |
8.1% |
| Thrombocytopenia |
6.7% |
| Tremor |
6.5% |
| Pyrexia |
6.1% |
| Myocardial Infarction |
3.9% |
| Renal Failure |
3.9% |
| Renal Failure Acute |
3.9% |
| Sepsis |
3.7% |
| Pruritus |
3.5% |
| Syncope |
3.5% |
| Respiratory Failure |
3.0% |
| Dyspnoea |
2.8% |
| Loss Of Consciousness |
2.8% |
| Neuropathy Peripheral |
2.6% |
| Cardiac Arrest |
2.4% |
| Nausea |
2.4% |
| Shock |
2.4% |
| Urticaria |
2.4% |
|
| Secondary |
| Colon Cancer |
21.9% |
| Colorectal Cancer |
12.2% |
| Colorectal Cancer Metastatic |
12.0% |
| Drug Use For Unknown Indication |
9.2% |
| Rectal Cancer |
8.0% |
| Premedication |
5.1% |
| Metastatic Gastric Cancer |
3.7% |
| Gastric Cancer |
3.5% |
| Colon Cancer Metastatic |
3.2% |
| Adenocarcinoma Of Colon |
2.9% |
| Pancreatic Carcinoma |
2.4% |
| Product Used For Unknown Indication |
2.4% |
| Nausea |
2.3% |
| Metastatic Colorectal Cancer |
2.0% |
| Neoplasm Malignant |
1.8% |
| Colon Cancer Stage Iii |
1.8% |
| Prophylaxis |
1.6% |
| Non-small Cell Lung Cancer |
1.5% |
| Hypertension |
1.4% |
| Metastases To Liver |
1.3% |
|
| Vomiting |
18.6% |
| Wound Dehiscence |
10.7% |
| Tremor |
8.0% |
| Pulmonary Embolism |
7.0% |
| Pyrexia |
6.0% |
| Thrombocytopenia |
4.8% |
| Acute Respiratory Distress Syndrome |
4.6% |
| Respiratory Failure |
4.6% |
| Neuropathy Peripheral |
3.5% |
| Renal Failure |
3.5% |
| Bronchial Disorder |
3.2% |
| Death |
3.2% |
| Renal Failure Acute |
3.2% |
| Nausea |
3.0% |
| Paraesthesia |
3.0% |
| Weight Decreased |
3.0% |
| Urinary Tract Infection |
2.6% |
| Diarrhoea |
2.5% |
| Laryngospasm |
2.5% |
| Pneumonia |
2.5% |
|
| Concomitant |
| Drug Use For Unknown Indication |
16.8% |
| Colon Cancer |
10.6% |
| Colorectal Cancer Metastatic |
9.3% |
| Premedication |
8.2% |
| Prophylaxis Of Nausea And Vomiting |
7.1% |
| Colorectal Cancer |
5.4% |
| Pancreatic Carcinoma |
5.0% |
| Adenocarcinoma Of Colon |
4.8% |
| Hypertension |
4.8% |
| Bile Duct Cancer |
4.1% |
| Product Used For Unknown Indication |
3.7% |
| Colon Cancer Metastatic |
3.0% |
| Gastric Cancer |
2.8% |
| Ovarian Epithelial Cancer |
2.6% |
| Rectal Cancer |
2.4% |
| Atrial Fibrillation |
2.2% |
| Adenocarcinoma |
1.9% |
| Non-hodgkin's Lymphoma |
1.9% |
| Chemotherapy |
1.7% |
| Rheumatoid Arthritis |
1.7% |
|
| Thrombocytopenia |
12.4% |
| Vomiting |
10.3% |
| Tremor |
8.2% |
| Death |
7.2% |
| Malignant Neoplasm Progression |
7.2% |
| Tongue Haematoma |
5.2% |
| Weight Decreased |
5.2% |
| White Blood Cell Count Decreased |
5.2% |
| Disease Progression |
4.1% |
| Metastases To Lymph Nodes |
4.1% |
| Neuropathy Peripheral |
4.1% |
| Sepsis |
4.1% |
| Tooth Loss |
4.1% |
| Mucosal Inflammation |
3.1% |
| Pulmonary Embolism |
3.1% |
| Rash |
3.1% |
| Renal Failure Acute |
3.1% |
| Abdominal Pain |
2.1% |
| Cardiomyopathy |
2.1% |
| Chills |
2.1% |
|
| Interacting |
| Colon Cancer |
37.0% |
| Colon Cancer Metastatic |
14.8% |
| Osteoporosis |
14.8% |
| Crohn's Disease |
7.4% |
| Nausea |
7.4% |
| Product Used For Unknown Indication |
7.4% |
| Hypertension |
3.7% |
| Sleep Disorder Therapy |
3.7% |
| Vomiting |
3.7% |
|
| Drug Interaction |
57.1% |
| Thrombocytopenia |
28.6% |
| Hypothermia |
14.3% |
|
